Proteomics International Laboratories’ “PromarkerD” testing has shown a high accuracy in predicting future kidney disease in type 1 diabetes patients. Proteomics International Laboratories’ “PromarkerD” testing has shown a high accuracy in predicting future kidney disease in type 1 diabetes patients. Business / Companies Sydney Morning Herald – Business
Proteomics testing pinpoints future kidney disease risks
